Skip to content

Effects of Transcutaneous Electrical acupoint Stimulation on Postoperative Delirium in cardiac valve replacement with Cardiopulmonary bypass patients

Effects of Transcutaneous Electrical acupoint Stimulation on Postoperative Delirium in cardiac valve replacement with Cardiopulmonary acupuncture bypass patients

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR1900002827
Enrollment
Unknown
Registered
2019-12-12
Start date
2019-12-12
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Delirium

Interventions

Sponsors

The Second Affiliated Hospital of Guangzhou University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
45 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Scheduled or limited for cardiac valve replacement with Cardiopulmonary acupuncture bypass patients aged 40 to 75 years old; 2. ASA I-III; 3. First thoracotomy; 4. Signed the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Suffered from the contraindication of TEAS including the local skin breakage, infection or planted with the electrophysiology device; 2. Unable to communicate and coordinate with the researcher, such as suffering from language comprehension deficits or mental diseases; 3. Certain/suspicious addiction with alcohol, analgenics or other drugs; 4. Preoperative placed intra-aortic balloon pump or ventricular assist device; 5. Severe dysfunction of liver or kidney meaning one of ALT, AST, ALP or TBIL is 2 times higher that normal or creatinine clearance 177umol/L; 6. Non-first-time thoracotomy; 7. Emergency surgery; 8. Participate in the other clinical trial 3 month before the enrollment.

Design outcomes

Primary

MeasureTime frame
Delirium scale (CAM-CR) score;

Secondary

MeasureTime frame
the expression of interleukin 17a (IL-17A) in serum;the expression of S100 beta protein in serum;

Countries

China

Contacts

Public ContactBin Jia

The Second Affiliated Hospital of Guangzhou University of Chinese Medicine

jiabin_11@163.com+86 13760784739

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026